Project Grant R01GM162977
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $433,125 to the University of California, Los Angeles (UCLA) effective August 1, 2025, through May 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This Project Grant supports a multidisciplinary research initiative investigating how genomic variation drives functional changes at molecular, cellular, and phenotypic levels. The research integrates cutting-edge...
- Federal Project Grant Award Summary The University of California, Los Angeles (UCLA) received a $420,984 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. This award supports the development of statistical methods and computational approaches to interpret deep mutational scanning (DMS) data, a high-throughput experimental technique used...
- Federal Project Grant Award Summary The University of California, Los Angeles received a $267,098 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) awarded August 1, 2025, with completion targeted for April 30, 2029. The award supports the development of statistical and computational methods for inferring Gene Regulatory Networks (GRNs) from large-scale RNA sequencing data. The research addresses two...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $385,000 to The Leland Stanford Junior University, effective March 1, 2026, through December 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research to elucidate the physical and chemical principles governing three-dimensional (3D) genome folding in individual cells. The principal investigator will conduct...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, Los Angeles a $433,125 Project Grant effective September 1, 2025 through August 31, 2030 under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of efficient algorithms for rapid searching and identification of known and novel small molecules within large mass spectral databases. The research addresses a...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $380,540 Project Grant to the University of California, Irvine, effective September 1, 2025, through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds investigator-initiated research examining epigenetic regulation mechanisms in human embryonic stem cell (hESC) lineage specification, with particular focus on the interplay between DNA...
- Federal Project Grant Award Summary The University of California, Los Angeles (UCLA) received a $433,125 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 5, 2026, with completion scheduled for January 31, 2031. The award supports the Rowat Lab's research initiative titled "Mapping the Mechanome: A Systems-Level Understanding of Mechanical Mediators and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $501,000 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) on September 5, 2025, for a project titled "Bridging the Gap Between Prediction and Reality in Structural Biology." This five-year project, concluding May 31, 2030, focuses on developing computational tools and methodologies to advance...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $361,952 to the University of California, Berkeley, effective September 1, 2025 through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research focused on developing experimental methods to systematically explore the mutational landscape of biomedically relevant proteins, specifically CRISPR-Cas genome...
The National Institute of General Medical Sciences (NIGMS) awarded a $363,570 Project Grant to the University of California, Los Angeles (UCLA) effective March 15, 2026, through February 28, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award funds the development of integrative computational and analytical methods to reconstruct three-dimensional (3D) genome structures from single cells by combining imaging data with multi-omics datasets. The project will deliver advanced probabilistic approaches capable of achieving 100-fold improvements in resolution and coverage compared to imaging-only methodologies, enabling unprecedented analysis of genome organization at approximately 200 kilobase resolution or better. The research initiative encompasses three primary deliverables: (1) development of integrative genome modeling methods that synthesize sparse imaging and multi-omics data to infer high-resolution single-cell 3D genome structures while minimizing experimental bias; (2) structure-function mapping analysis of three-dimensional regulatory architecture in mouse embryonic stem cells and brain cortex tissue to systematically classify genes by their regulatory microenvironments and their roles in gene expression; and (3) expansion of the Integrative Genome Modeling (IGM) platform for broader application. These products will advance fundamental understanding of gene regulation, chromatin architecture, and epigenetic processes critical to cellular function and development.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $363.6k | 3/12/26 |